HGH-191AA (Somatropin)
Research use only.
High-purity research-grade HGH-191AA (Somatropin)
HGH-191AA (Somatropin) is a recombinant form of human growth hormone extensively studied for its role in growth regulation, tissue repair, metabolic function, and cellular regeneration. Structurally identical to endogenous growth hormone, Somatropin is commonly explored in research involving body composition, recovery from physiological stress, bone density, and age-related hormonal decline. Its broad systemic effects on growth and metabolism have made it one of the most widely studied peptides in endocrine and regenerative research.
Product overview
HGH-191AA (Somatropin) is a synthetic 191-amino-acid peptide that mimics naturally produced human growth hormone (hGH). It binds to growth hormone receptors throughout the body, influencing downstream production of insulin-like growth factor 1 (IGF-1), which plays a key role in growth, repair, and metabolic regulation. Research involving Somatropin has focused on its effects on muscle anabolism, fat metabolism, tissue regeneration, and overall physiological maintenance in experimental models of deficiency and aging.
Key research features
Supports growth hormone signaling: Studies indicate Somatropin may increase circulating IGF-1 levels, contributing to enhanced anabolic activity, protein synthesis, and cellular growth signaling pathways. These mechanisms are central to its widespread investigation in growth and recovery research.
Tissue repair and regeneration: Research suggests HGH-191AA may support connective tissue repair, muscle recovery, and cellular regeneration following physical or metabolic stress. Experimental models have shown interest in its role in healing and structural tissue maintenance.
Body composition and metabolic research: Somatropin has been extensively studied for its potential to support lean muscle mass development, reduce adipose tissue accumulation, and improve overall metabolic efficiency through enhanced lipolysis and nutrient partitioning.
Bone density and structural support: Early research indicates HGH may contribute to bone remodeling and mineral density maintenance through IGF-1 mediated pathways, making it a key focus in skeletal health and aging-related studies.
HGH-191AA (Somatropin) Suggested Use:
Typical Dose: 1–4 IU per day (research range)
Route: Subcutaneous injection
Frequency: Once daily (or split dosing depending on protocol)
Duration: 8–16 weeks, or as recommended by a healthcare professional